Online Investor Presentation

RNS Number : 6213I

Accrol Group Holdings PLC

15 December 2020

 

RNS Reach

15 December 2020

ACCROL GROUP HOLDINGS PLC
("Accrol" or the "Group")

AIM: ACRL

ONLINE INVESTOR PRESENTATION

Accrol Group, one of the UK's leading independent tissue converters, is pleased to announce that following the successful acquisition of Leicester Tissue Company ("LTC") in November 2020, the Group's CEO senior management team is hosting a presentation to provide retail investors with background on Accrol, the Board's strategy and ambitions and the rationale for the acquisition of LTC.

The webinar will take place at 2.00pm today, 15 December 2020, via Zoom.

If you would like to join the webinar, please email [e-mail], who will provide login details. 

For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman	Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Zeus Capital Limited (Nominated Adviser & Broker)
Dan Bate / Jordan Warburton	Tel: [phone]
Dominic King / John Goold	Tel: [phone]
Liberum Capital Limited (Joint Broker)	Tel: [phone]
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine	Tel: [phone]
Keeley Clarke	Tel: [phone]
Llew Angus	Tel:  [phone]
	[e-mail]

Overview of Accrol

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisition of a state-of-the-art tissue converter based in Leicester, the Group now operates from five sites, including four in Lancashire, which generate revenues totalling c.16% of the £1.7bn UK retail tissue market.

 

END

 

 

NRABIBDDIDBDGGS